Logo
x

Search category

Subscribe Now

advanced solid tumors

BridgeBio Enters into Clinical Collaboration with BMS to Evaluate BBP-398 + Opdivo for Advanced Solid Tumors with KRAS Mutations

BridgeBio Enters into Clinical Collaboration with BMS to Evaluate BBP-398 + Opdivo for Advanced Solid Tumors with KRAS Mutations

  • July 28, 2021
Hutchmed Initiates P-I Trial of HMPL 295 for the Treatment of Advanced Solid Tumors in China

Hutchmed Initiates P-I Trial of HMPL 295 for the Treatment of Advanced Solid Tumors in China

  • July 6, 2021
Bayer Seeks Approval of Larotrectinib for Advanced Solid Tumors in China

Bayer Seeks Approval of Larotrectinib for Advanced Solid Tumors in China

  • May 25, 2021
Exelixis Reports the US FDA's Acceptance of IND for XB002 in Patients with Advanced Solid Tumors

Exelixis Reports the US FDA's Acceptance of IND for XB002 in Patients with Advanced Solid Tumors

  • April 6, 2021
Strata Oncology Collaborates with Mirati Therapeutics to Broaden Enrollment in Clinical Trial of MRTX849 for Patients with Advanced Solid Tumors

Strata Oncology Collaborates with Mirati Therapeutics to Broaden Enrollment in Clinical Trial of MRTX849 for Patients with Advance...

  • August 13, 2020
BioInvent Collaborates with MSD to Evaluate BI-1206 in Combination with Keytruda (pembrolizumab) for Advanced Solid Tumors

BioInvent Collaborates with MSD to Evaluate BI-1206 in Combination with Keytruda (pembrolizumab) for Advanced Solid Tumors

  • December 18, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.